American Capital Advisory, LLC Roivant Sciences Ltd. Transaction History
American Capital Advisory, LLC
- $185 Billion
- Q1 2025
A detailed history of American Capital Advisory, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, American Capital Advisory, LLC holds 19 shares of ROIV stock, worth $220. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19Holding current value
$220% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
322Shares Held
504MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$765 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$721 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$556 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$512 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$411 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.18B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...